DEFINITION of demyelination

Demyelination is the pathological stripping, destruction, or loss of myelin — the multilayered lipid-protein sheath produced by oligodendrocytes in the CNS and Schwann cells in the PNS — from the axons it insulates and supports. Myelin functions as both an electrical insulator and a metabolic support structure for axons; its loss dramatically slows or completely blocks saltatory conduction of nerve impulses along affected fibers, producing functional deficits proportional to the location and severity of myelin damage. The resulting neurological impairments span an enormous clinical spectrum depending on which neural pathways are affected: motor deficits, sensory disturbances, visual loss, cognitive dysfunction, ataxia, autonomic dysregulation, and more. Demyelination is the unifying pathologic mechanism shared by a diverse group of diseases — collectively called demyelinating diseases — which are traditionally divided into myelinoclastic disorders (in which normally formed myelin is destroyed by immune attack, toxic injury, or ischemia) and dysmyelinating / leukodystrophic disorders (in which myelin is inherently abnormal due to metabolic or genetic defects). As an inpatient profee coder, demyelination itself is not a standalone ICD-10-CM billable code — it is the mechanism that drives a specific disease-level code. Your job is to identify which demyelinating disease is documented: G35.x (MS — now fully expanded in FY2026), G36.x (acute disseminated demyelination including NMO/Devic), G37.x (other CNS demyelinating diseases including MOGAD G37.81, Balo’s concentric sclerosis G37.5, and central pontine myelinolysis G37.2), or a peripheral demyelinating disorder like GBS (G61.0) or CIDP (G61.81). Demyelination documented without a specific disease etiology maps to G37.9.


ETYMOLOGY of demyelination

greek latin

ComponentOriginMeaning
de-Latin prefix de-Removal of / reversal / loss” — indicates the stripping away or undoing of the named substance or structure
myel-Ancient Greek μυελός (myelos)Marrow / spinal cord” — the Greek root originally referred to bone marrow and spinal cord; in modern medicine it specifically denotes the myelin sheath of nerve fibers
-inLatin/French chemical suffixSubstance” — chemical/biological suffix denoting a lipid or protein compound; myelin = the lipid-rich insulating compound surrounding axons
-ationLatin verbal noun suffix -atioProcess / action of” — converts the verb demyelinate into a noun denoting the act or process of myelin loss

The word myelin was coined by German pathologist Rudolf Virchow in 1854, derived from the Ancient Greek μυελός (myelos, “marrow”) because the fatty white substance sheathing nerve fibers bore visual resemblance to the white of bone marrow. The prefix de- (Latin: away, removal of) was later affixed to form the verb demyelinate and noun demyelination in the late 19th and early 20th centuries as neuropathologists characterized the diseases causing myelin loss. The combining form myel- remains one of the most productive roots in neurology, yielding myelopathy, myelitis, myeloma, myelin, poliomyelitis, and the imaging prefix MRI myelography. The root should not be confused with myos- (muscle) — a distinction that is critical for accurate medical terminology and coding alike.


🔀 ALIASES / ALTERNATE TERMS

  • Demyelinating disease (umbrella term for all conditions characterized by myelin destruction or loss)
  • Demyelinating disorder (clinical synonym — same scope)
  • Inflammatory demyelinating disease (IDD) (subset driven by autoimmune/inflammatory mechanisms — MS, NMO, ADEM, MOGAD)
  • Myelinoclastic disease (classically formed myelin is destroyed by external insult — immune attack, toxin, ischemia)
  • Dysmyelination / Leukodystrophy (myelin is formed abnormally due to genetic/metabolic defect — Krabbe, metachromatic leukodystrophy, adrenoleukodystrophy)
  • White matter disease (radiologic descriptor for CNS demyelinating lesions; includes vascular and inflammatory subtypes)
  • Leukoencephalopathy (disease of the white matter — broader term that includes demyelinating and non-demyelinating etiologies)
  • ADEM (Acute Disseminated Encephalomyelitis — monophasic inflammatory demyelination post-infection or vaccination)
  • NMO / Devic disease (Neuromyelitis Optica — anti-AQP4 antibody-mediated demyelination of optic nerves and spinal cord)
  • MOGAD (Myelin Oligodendrocyte Glycoprotein Antibody Disease — anti-MOG mediated demyelinating spectrum; new FY2026 code G37.81)
  • CIDP (Chronic Inflammatory Demyelinating Polyneuropathy — PNS demyelinating disease; autoimmune; coded G61.81)
  • GBS (Guillain-Barré Syndrome — acute PNS demyelinating disease post-infection; coded G61.0)
  • Central pontine myelinolysis (CPM) (osmotic demyelination syndrome — rapid sodium correction; coded G37.2)
  • Osmotic demyelination syndrome (ODS) (broader term encompassing CPM and extrapontine myelinolysis)

🔗 RELATED TERMS

  • Myelin — the lipid-rich multilayered sheath produced by oligodendrocytes (CNS) and Schwann cells (PNS); primary target in demyelinating disease
  • Oligodendrocyte — CNS glial cell responsible for producing and maintaining myelin around multiple axons simultaneously
  • Schwann cell — PNS equivalent of the oligodendrocyte; each Schwann cell myelinates one axon segment
  • Axon — the nerve fiber projection along which electrical impulses travel; demyelination slows or blocks conduction; severe disease causes secondary axonal loss
  • Saltatory conduction — the mechanism by which action potentials “jump” between nodes of Ranvier in myelinated fibers, enabling rapid signal transmission; abolished by demyelination
  • Plaque — focal area of demyelination and gliosis in the CNS; the histopathologic and MRI unit of MS and related demyelinating diseases
  • Node of Ranvier — gaps in the myelin sheath where ion exchange occurs during signal propagation; demyelination disrupts this mechanism
  • Optic neuritis — inflammation and demyelination of the optic nerve; hallmark presentation of MS, NMO, and MOGAD; coded H46.11/H46.12
  • Transverse myelitis — acute demyelinating inflammation of the spinal cord; cord lesion producing weakness, sensory loss, and bladder dysfunction; coded G37.3
  • ADEM (Acute Disseminated Encephalomyelitis) — monophasic inflammatory demyelination typically post-viral or post-vaccination; coded G36.9 or G36.8
  • Devic disease — anti-AQP4 antibody-mediated demyelination; distinct from MS; coded G36.0
  • MOGAD — anti-MOG antibody disease; cortical demyelination with ADEM, optic neuritis, or myelitis phenotype; FY2026 new code G37.81
  • Guillain-Barré syndrome — acute autoimmune PNS demyelination post-infectious; ascending paralysis; coded G61.0
  • CIDP — chronic autoimmune PNS demyelination; treated with IVIG, plasmapheresis, steroids; coded G61.81
  • Central pontine myelinolysis (CPM) — osmotic demyelination of pons from rapid hyponatremia correction; coded G37.2
  • NMO antibody — serum antibody targeting aquaporin-4 water channel; specific for NMO/Devic disease; negative in MS and MOGAD
  • MOG-IgG — anti-myelin oligodendrocyte glycoprotein antibody; diagnostic for MOGAD spectrum; negative in MS and NMO
  • IVIG (intravenous immunoglobulin) — immunomodulatory infusion therapy; first-line for GBS and CIDP; also used in ADEM
  • PLEX — therapeutic plasma exchange removing pathogenic antibodies; used in NMO relapses, GBS, CIDP, severe ADEM

CODING CORNER


🏥 ICD-10-CM CODES

CNS Demyelinating Diseases — Block G35-G37

(Chapter 6: Diseases of the Nervous System — G35-G37 = Demyelinating Diseases of the CNS) (⚠️ Demyelination alone is NOT a billable code — always assign the specific disease-level code)

Multiple Sclerosis — Category G35

(⚠️ FY2026: G35 parent is no longer billable — must use subcategory)

CodeDescription
G35.ARelapsing-remitting multiple sclerosis (RRMS) — ⚠️ HCC
G35.B0Primary progressive MS, unspecified activity — ⚠️ HCC
G35.B1Active primary progressive MS — ⚠️ HCC
G35.B2Non-active primary progressive MS — ⚠️ HCC
G35.C0Secondary progressive MS, unspecified activity — ⚠️ HCC
G35.C1Active secondary progressive MS — ⚠️ HCC
G35.C2Non-active secondary progressive MS — ⚠️ HCC
G35.DMultiple sclerosis, unspecified (last resort; includes disseminated MS, generalized MS NOS)⚠️ HCC
Acute Disseminated Demyelination — Category G36

(Includes NMO/Devic, ADEM, Hurst disease — G36 parent is NOT billable)

CodeDescription
G36.0Neuromyelitis optica (NMO / Devic disease) (anti-AQP4 mediated; Excludes1 from G35 — NOT MS)⚠️ CC
G36.1Acute and subacute hemorrhagic leukoencephalitis (Hurst disease) (hyperacute variant of ADEM; hemorrhagic; high mortality)
G36.8Other specified acute disseminated demyelination (ADEM with specified features not covered by G36.0-G36.1)
G36.9Acute disseminated demyelination, unspecified (ADEM NOS — use when post-infectious/post-vaccination CNS demyelination is documented without further specification)
Other CNS Demyelinating Diseases — Category G37

(G37 parent is NOT billable — includes important FY2026 new code for MOGAD)

CodeDescription
G37.0Diffuse sclerosis of CNS (Schilder disease / X-linked adrenoleukodystrophy-like presentation)
G37.1Central demyelination of corpus callosum (Marchiafava-Bignami disease — thiamine/alcohol related)
G37.2Central pontine myelinolysis (osmotic demyelination syndrome from rapid sodium correction)⚠️ CC
G37.3Acute transverse myelitis in demyelinating disease of CNS (spinal cord demyelination — motor/sensory/bladder loss below lesion)⚠️ CC
G37.4Subacute necrotizing myelitis of CNS (Foix-Alajouanine syndrome — vascular/necrotizing myelopathy)
G37.5Concentric sclerosis of CNS (Balo disease) (rare aggressive variant of MS with onion-ring MRI pattern)
G37.81Myelin oligodendrocyte glycoprotein antibody disease (MOGAD) (⚠️ NEW FY2026 code — anti-MOG IgG positive demyelinating spectrum; cortical, optic nerve, and spinal cord involvement)⚠️ CC
G37.89Other specified demyelinating diseases of CNS
G37.9Demyelinating disease of CNS, unspecified (also used for Clinically Isolated Syndrome / CIS per FY2026 guidance)
PNS Demyelinating Diseases

(Peripheral nervous system — distinct from CNS demyelinating diseases above)

CodeDescription
G61.0Guillain-Barré syndrome (GBS) (acute autoimmune ascending PNS demyelination; post-infectious)⚠️ MCC
G61.81Chronic inflammatory demyelinating polyneuropathy (CIDP) (chronic autoimmune PNS demyelination; IVIG/PLEX dependent)⚠️ CC
G61.89Other inflammatory polyneuropathies (anti-MAG neuropathy, multifocal motor neuropathy)
G60.0Hereditary motor and sensory neuropathy (Charcot-Marie-Tooth disease — genetic PNS dysmyelination)
Associated / Complication Codes
CodeDescription
H46.11Retrobulbar neuritis, right eye (optic neuritis — demyelinating optic nerve inflammation)
H46.12Retrobulbar neuritis, left eye
H46.8Other optic neuritis
G82.20Paraplegia, unspecified (severe spinal cord demyelination/transverse myelitis sequela)
N31.9Neuromuscular dysfunction of bladder, unspecified (neurogenic bladder — spinal cord demyelination)
E51.11Dry beriberi (thiamine deficiency demyelination — PNS; relevant in Marchiafava-Bignami/Wernicke context)

🔧 COMMON CPT CODES (Demyelinating Disease Workup, Diagnostics & Treatment)

Neuroimaging — MRI Brain & Spine

CPT CodeDescription
70551MRI brain without contrast (T2/FLAIR lesion detection — periventricular, juxtacortical, infratentorial, spinal)
70552MRI brain with contrast (gadolinium-enhancing lesions = active blood-brain barrier breakdown / active demyelination)
70553MRI brain without and with contrast (preferred full protocol for demyelinating disease workup)
72141MRI cervical spine without contrast
72142MRI cervical spine with contrast (cervical cord lesions — MS, NMO, transverse myelitis, MOGAD)
72146MRI thoracic spine without contrast
72147MRI thoracic spine with contrast
72148MRI lumbar spine without contrast
72149MRI lumbar spine with contrast
72156MRI cervical spine without and with contrast
72157MRI thoracic spine without and with contrast
72158MRI lumbar spine without and with contrast

Neurophysiology — Evoked Potentials

(Critical for demonstrating dissemination in space along demyelinated pathways)

CPT CodeDescription
95930Visual evoked potential (VEP) testing (optic nerve demyelination; detects subclinical optic neuritis; supports DIS in MS/MOGAD/NMO workup)
95925Short-latency somatosensory evoked potential (SSEP), upper limbs (cervical cord / sensory pathway demyelination)
95926Short-latency SSEP, lower limbs (thoracic/lumbar cord demyelination — transverse myelitis, MS)
95938Short-latency SSEP, upper and lower limbs combined
95928Central motor evoked potential study (MEP), upper limbs (corticospinal tract demyelination)
95929Central motor evoked potential study (MEP), lower limbs
95939Central motor evoked potential study (MEP), upper and lower limbs combined
95923Autonomic function tests (quantitative sudomotor axon reflex — PNS autonomic demyelination in GBS/CIDP)

Nerve Conduction Studies / EMG

(Gold-standard electrophysiology for PNS demyelinating disease — GBS, CIDP, CMT)

CPT CodeDescription
95907Nerve conduction studies; 1-2 studies (NCS — reduced conduction velocity, prolonged distal latency, conduction block in PNS demyelination)
95908Nerve conduction studies; 3-4 studies
95909Nerve conduction studies; 5-6 studies
95910Nerve conduction studies; 7-8 studies
95911Nerve conduction studies; 9-10 studies
95912Nerve conduction studies; 11-12 studies
95913Nerve conduction studies; 13 or more studies
95860Needle electromyography (EMG); 1 extremity (rules out axonal loss vs. demyelination; assesses reinnervation in GBS)
95861Needle EMG; 2 extremities
95863Needle EMG; 3 extremities
95864Needle EMG; 4 extremities

Cerebrospinal Fluid / Lumbar Puncture

CPT CodeDescription
62270Spinal puncture, lumbar, diagnostic (LP — oligoclonal bands, IgG index, cell count, protein for MS/NMO/ADEM/MOGAD)
83519Immunoassay for analyte other than antibody or antigen, quantitative (CSF IgG index, kappa free light chains)
86255Fluorescent antibody; screen (AQP4-IgG / NMO antibody — rules in NMO, rules out MS)
86596Anti-MOG IgG antibody (MOG antibody — diagnoses MOGAD; negative in MS and NMO)
86235Nuclear antigen antibody panel (ANA — rules out SLE/CTD mimicking demyelinating disease)
84145Procalcitonin (rules out infectious myelitis/encephalitis mimicking ADEM)

Treatment — IV Infusion Therapies

CPT CodeDescription
96365IV infusion, therapeutic/prophylactic/diagnostic; initial, up to 1 hour (IVIG — GBS, CIDP, ADEM, MOGAD; methylprednisolone — NMO/MS relapse; natalizumab, ocrelizumab — MS DMT)
96366IV infusion, each additional hour (add-on — IVIG infusions routinely 4-6 hours; ocrelizumab 3+ hours)
96367IV infusion, additional sequential drug, up to 1 hour
96368IV infusion, concurrent, each additional drug
96413Chemotherapy administration, IV infusion, up to 1 hour (cyclophosphamide — aggressive MS/MOGAD/NMO induction)
96415Chemotherapy administration, IV infusion, each additional hour (add-on to 96413)

Therapeutic Apheresis

(For severe steroid-refractory demyelinating disease relapses — NMO, GBS, CIDP, ADEM)

CPT CodeDescription
36514Therapeutic apheresis; for plasma pheresis (PLEX/plasmapheresis — NMO relapse, GBS, CIDP, steroid-refractory ADEM; typically 5-7 exchanges)

Rehabilitation

CPT CodeDescription
97110Therapeutic exercises (PT for weakness, spasticity, ataxia from CNS/PNS demyelination — 15-minute units)
97112Neuromuscular reeducation (PT/OT for balance, coordination, proprioception deficits)
97530Therapeutic activities (ADL retraining — OT for demyelination-related functional limitations)
96125Standardized cognitive performance testing per hour (neuropsychological testing for cognitive demyelination in MS/ADEM)

⚠️ Coding Note: Demyelination is a mechanism, not a billable ICD-10-CM code — always assign the specific disease-level code. The most important FY2026 addition to this category is G37.81 (MOGAD) — myelin oligodendrocyte glycoprotein antibody disease is now its own distinct code after years of being buried in G36.8 or G37.89. Any chart documenting anti-MOG IgG positivity with a demyelinating phenotype (optic neuritis, myelitis, cortical encephalitis) should now map to G37.81, not a G35.x MS code. G36.0 (NMO/Devic) carries an Excludes1 from G35 — it cannot be coded alongside any G35.x MS code; these are distinct entities with different serology, treatment, and prognosis. G37.2 (central pontine myelinolysis) requires a cause code — osmotic demyelination is almost always precipitated by rapid sodium correction in hyponatremia; the underlying electrolyte disorder should be sequenced first. For PNS demyelination, G61.0 (GBS) is an MCC and is frequently the principal diagnosis driving ICU-level admissions with mechanical ventilation — ensure plasmapheresis (36514) and IVIG (96365-96366) are fully captured on the profee claim. G61.81 (CIDP) is a CC and is commonly seen on complex neurology and infusion admissions — IVIG is the standard recurring treatment and each infusion encounter should have separately billed 96365 + 96366 add-on hours. For NCS/EMG: nerve conduction studies (95907-95913) and needle EMG (95860-95864) are separately billable but must be performed and interpreted by the same provider on the same date — don’t let the bundle rules catch you; verify documentation supports both components.



Med roots Appendix A Prefixes Appendix B Combining Forms Appendix C Suffixes Appendix D Suffix forms